ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

NCI Awards STRAP Grant Of $2 Million To MSKCC

October 22, 2010

Obit: John Ultmann, A Leader In Clinical Oncology.

October 27, 2000

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010

AACR President: Cancer Program ‘Threatened,’ Calls For Strategic Plan, More Extramural Input

December 6, 1991

Board of Scientific Advisors discussion: Are peer reviewers correctly interpreting the guidelines?

March 19, 2004

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013